TOTAL VOLUME:
$134b
24H VOL:
$107,351,958
24H TRANSACTIONS:
2,388,728,490
OPEN INTEREST:
$1,416,970,024
400,720
Markets across
30,097
events
MATCHED EVENTS:
2,633
PLATFORM COVERAGE:
5
Polymarket:
39%
VS.
Kalshi:
61%
Closed: Aug 10, 4:38 PM EST
Kalshi
This market tracks whether Hims & Hers Health Inc. will report subscriber growth exceeding 2.62 million during the second quarter of 2026. On Kalshi, the leading outcome currently stands at 97.0%. Resolution will be determined by the company's official Q2 2026 subscriber count as reported in their earnings disclosure. Watch for Hims & Hers' Q2 2026 earnings announcement on or around September 2, 2026, when the company will disclose its subscriber metrics and resolve this market.
Resolution is based on Hims & Hers Health Inc.'s reported subscriber count in Q2 2026, with thresholds ranging from 2.6 million to 3.04 million subscribers. Each threshold operates as an independent outcome: if the reported subscriber count exceeds a given threshold, that corresponding outcome resolves to Yes. The company's official quarterly earnings report or investor disclosure for Q2 2026 serves as the authoritative source for subscriber figures.
The Hims & Hers subscribers in Q2 market resolves on Sep 2, 2026. Resolution is contingent on Hims & Hers Health Inc. publishing official Q2 2026 subscriber figures in their earnings report or investor communications. The outcome hinges on whether reported subscribers exceed 2.72 million at quarter-end. Once the company discloses subscriber count, the market settles based on that official figure. Traders should monitor earnings calendars and press releases for the exact timing of Q2 results announcement.
Key catalysts include quarterly earnings releases, management guidance revisions, and subscriber growth announcements from Hims & Hers. Competitive dynamics in telehealth and GLP-1 prescription services could impact subscriber acquisition and retention. Regulatory changes affecting prescription delivery or telehealth reimbursement may influence growth trajectories. Clinical trial results or new product launches by Hims & Hers could accelerate subscriber additions. Macroeconomic shifts affecting consumer spending on healthcare services and market sentiment toward digital health companies will also influence trader positioning. Media coverage of subscriber milestones or competitive threats may drive price movements on Kalshi.